News
-
FDA approves Cyramza
Tuesday | Apr 22 2014The US Food and Drug Administration (FDA) has approved Cyramza (ramucirumab) for use in patients with.
-
August price reduction
Tuesday | Apr 22 2014The 01 Aug price reductions for the 2014 supplementary cycle A have been released, with only.
-
Electronic drug track
Tuesday | Apr 22 2014The US Food and Drug Administration (FDA) is working with The Drug Supply Chain Security Act,.
-
SHPA forum and chat
Tuesday | Apr 22 2014The Society of Hospital Pharmacists of Australia (SHPA) is inviting members to sign up for its.
-
FDA nods Ragwitek
Tuesday | Apr 22 2014The US Food and Drug Administration (FDA) has approved Ragwitek to treat ragweed pollen induced allergic.
-
API’s $131m impairment
Tuesday | Apr 22 2014Australian Pharmaceutical Industries Ltd (API) announced it would incur an asset impairment charge of $131m (PD.
-
TGA Cilantro alert
Tuesday | Apr 22 2014THE Therapeutic Goods Administration (TGA) said investigations had shown people in Australia may have bought Swanson.
-
False Herceptin alert
Tuesday | Apr 22 2014The European Medicines Agency (EMA) is warning healthcare professionals across the EU to be aware that.
-
PD breaking news – API posts $131m asset impairment charge
Thursday | Apr 17 2014API slashes asset values by $131m.
-
TWC flu vax controversy
Thursday | Apr 17 2014Conflict of interest queries have been raised about the Queensland Pharmacist Immunisation Pilot (QPIP) with the.